Trial Profile
Botulinum Toxin Type A Block of the Otic Ganglion in Chronic Cluster Headache: Safety Issues
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 07 Apr 2022
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Cluster headache
- Focus Adverse reactions
- 25 Mar 2020 Status changed from recruiting to completed.
- 30 Apr 2018 Planned End Date changed from 1 Jun 2018 to 1 Dec 2019.
- 30 Apr 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2019.